Purpose: Replication error is an important mechanism in carcinogenesis. The microsatellite instability (MSI-H) of colorectal cancers is associated with the development of multiple cancers. The influence of MSI-H on the development of multiple gastric cancers in sporadic gastric cancer patients has not been defined. This study was performed to reveal the association between the clinicopathologic features and MSI in sporadic gastric cancers. Materials and Methods: Between July 2004 and March 2009, the clinicopathologic characteristics, including MSI status, were evaluated in 128 consecutive patients with sporadic gastric cancers. None of the patients had hereditary non-polyposis colorectal cancer of familial gastric cancer. The markers that were recommended by the NCI to determine the MSI status for colorectal cancers were used. Results: MSI-H cancers were found in 10.9% of the patients (14/128). Synchronous gastric cancers were shown in 4 patients (3.1%).
Materials and Methods
The patients
One hundred twenty-eight patients who were diagnosed with gastric cancer between July 2004 and November 2009, underwent surgical resection, and were pathologically-diagnosed with gastric adenocarcinoma were enrolled in the study. Eighty-eight patients were male and 40 patients were female. The mean age of the patients was 60.57±11.80 years. Eighty-six patients had advanced gastric cancer and 42 patients had early gastric cancer. Gastric adenocarcinoma was classified according to the Japanese Gastric Cancer Association (JGCA) classification as well differentiated, moderately differentiated, poorly differentiated, mucinous, and signet ring cell. Based on the time of diagnosis, patients diagnosed at the same time or within 6 months were considered to be synchronous cancer, and cases diagnosed 6 months after the diagnosis of primary cancer were classified as metachronous cancer. (9) The mean duration of follow-up was 4.12±1.13 years. During the follow-up period, none of patients developed metachronous gastric cancer or secondary cancers in other organs.
Sampling and DNA extraction
Tissue slides of 128 patients were examined under a light microscope, and DNA was extracted from normal and tumor tissues of tissue sections stained with HE. The tissues were sonicated in 600 μl of nucleic lysis solution, and the lysate was collected and in- sequence of two nucleotides, were selected as PCR primers for the assessment of MSI. (10) The microsatellite loci were amplified by PCR using radiolabeled oligonucleotide primers, the length was analyzed by gel electrophoresis or autoradiography, and the difference between normal tissues and cancer tissues was examined.
With respect to MSI, if the DNA of tumor tissues show new bands in comparison with normal tissues, it was considered to be MSI.
The loss of an allelic gene was not considered to be MSI (Fig. 1) .
In our study, according to the guideline of the National Cancer Institute (Bethesda, Maryland, MD, USA), 5 markers were selected. Cases positive for ＞2 markers were considered to be highfrequency MSI (MSI-H), while cases positive for ＜2 markers were considered to be low-frequency MSI (MSI-L) or microsatellite stable (MSS). (11) Only MSI-H was considered to be the satellite instability group, and MSI-L or MSS was referred to as the satellite stability group.
Data analysis and statistics
In the comparison of clinicopathologic characteristics for univariate analysis, a chi-square test was performed; for multivariate analysis, multivariate logistic regression analysis was performed.
Among univariate factors, age and tumor size were consecutive variables, and other variables were categorical. The common analysis factors for multivariate analysis were gender and age. (12) In the current study, MSI, the location of the tumor, disease stages reported to be statistically significant in other studies,(13) differentiation, (14) and advanced or early gastric cancer were included. SPSS (ver. 17.0; SPSS, Inc., Chicago, IL, USA) was used. A P-value＜0.05 was considered to be statistically significant.
Results
One hundred twenty-eight gastric cancer patients underwent gastrectomies and were diagnosed by histologic evaluation; MSI Table 2 ). In multiple gastric cancer, the rate of MSI was 50%, which was shown to be significantly higher than single gastric carcinoma (9.6%).
Discussion
The mechanism by which gastric cancer develops is a multi-step process. Indeed, cancer develops by the accumulation of genetic or environmental changes inducing the dysfunction of genes. (15) The Cancer Institute for colorectal cancer were followed, among 14 patients in the MSI group, 13 patients were positive for the marker that has been shown to determine the phenotype of MSI, and it is considered that the criteria of the MSI-H group selected in our study were sufficient to be classified as the MSI group. Synchronous gastric cancer is detected in 4~10% of all gastric cancers. (3) In addition, the probability of patients treated with primary cancer developing a secondary cancer within 10 years is known to be approximately 10%. (21) The incidence of metachronous cancer is higher in multiple gastric cancer than single gastric cancer, (22) and thus if predictive factors are identified, which would be of help to improve the prognosis of patients. In addition, if multiple lesions are overlooked at the time of initial treatment, the incidence of metachronous gastric cancer could be increased after treatment, which becomes an important issue. (23) The results of the current study show that in the MSI group, the incidence of multiple gastric center was higher. Therefore, it is thought that MSI is a factor exerting effects on the development of multiple cancer not only in HNPCC, but also in sporadic gastric cancer.
According to the study reported by Nakashima, (20) in cases of MSI, the incidence of synchronous multiple gastric cancer was shown to be higher. Nevertheless, HNPCC was not excluded, and cancer in other organs, such as liver and colorectal cancer, were considered to be multiple cancer, and even MSI-L was considered as the MSI group. According to the study reported by Ribeiro, (13) the incidence of synchronous gastric cancer is high in MSI-H cases. However, in their study, hMLH1 was considered to be a marker for MSI-H, and instead of PCR-based mutational studies, the presence or absence of microsatellite changes was assessed by immunohistochemical staining. tests, which could be inferred from the finding that during 6 years of the entire study period, cases corresponding to 75% (3/4) were detected during the last 2 years. In addition, based on research results that generally, the onset time of metachronous gastric cancer after treatment is within an average of 10 years, (21) it is thought that 5.12±1.13 years of the follow-up observation period of our study is somewhat short to discuss the development of metachronous gastric cancer. It is thought that in the future, studies on metachronous cancer and primary cancer in other organs in a large scale patient group are needed.
In summary, the results of the current study show that the MSI group has the characteristic of intestinal type as reported previously, and particularly, in sporadic gastric cancer, it is thought to be associated with the development of synchronous multiple cancer.
Nevertheless, in order to apply it as a molecular biological factor that could predict the development of multiple gastric cancer, additional studies are needed. Therefore, in the MSI group, the possibility of the presence of synchronous multiple cancer as well as the possibility of the development of metachronous cancer in the future should be monitored carefully and the follow-up observation is required. In addition, it could be speculated that in multiple and single gastric cancer, the genetic pathologic mechanism due to genetic factors different from each other is involved.
